文献速递产科母胎医学

胎儿镜下激光消融治疗II型血管前置—病例报告与系统综述

Fetoscopic Laser Ablation of Type II Vasa Previa-Case Report and Systematic Review.
PubMed 文献 · Prenat Diagn · 2025-09-29

本文报告一例40岁孕3产0女性在22+5周诊断II型血管前置,于31+5周成功行胎儿镜下激光消融(FLA)无并发症,36+5周胎膜自破后应产妇要求行剖宫产分娩健康男婴。对文献54例的系统综述显示FLA技术成功率98.1%、阴道分娩率50%、新生儿存活率100%,未报告重大母体并发症。

要点

  • II型血管前置可选择胎儿镜下激光消融(FLA)作为微创替代方案。
  • 系统综述54例中FLA技术成功率98.1%、阴道分娩率50%、新生儿存活率100%。
  • 综述未报告FLA相关重大母体并发症。

核心结论

  • 这些发现提示,在选定患者中FLA可能为早产剖宫产提供一种安全有效的替代方案。

研究设计与样本

  • 病例报告:一例40岁孕3产0女性于22+5周诊断II型血管前置,31+5周行FLA,36+5周胎膜自破后应产妇要求行剖宫产。
  • 系统综述:汇总文献中54例接受FLA的病例。

主要发现

  • 病例报告中FLA于31+5周成功完成,无并发症;36+5周胎膜自破,应产妇要求行剖宫产分娩健康男婴。
  • 系统综述54例中,FLA技术成功率为98.1%,阴道分娩率为50%,新生儿存活率为100%。
  • 系统综述未报告重大母体并发症。

关键数值与推荐

  • FLA技术成功率98.1%(54例系统综述)。
  • FLA后阴道分娩率50%(54例系统综述)。
  • FLA后新生儿存活率100%(54例系统综述)。

临床怎么用

  • 当前血管前置的管理为在临产前计划性剖宫产。
  • FLA近期作为选定病例(尤其II型和III型血管前置)的微创替代方案出现,可延长妊娠并可能实现阴道分娩。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vasa previa is a rare but potentially fatal obstetric condition in which fetal vessels traverse the internal cervical os without the protection of placental tissue or Wharton's jelly, making them highly vulnerable to rupture during labor or spontaneous membrane rupture. This can result in rapid fetal exsanguination and death. While current management involves planned cesarean delivery before the onset of labor, fetoscopic laser ablation (FLA) has recently emerged as a minimally invasive alternative for selected cases, particularly type II and III vasa previa, allowing for pregnancy prolongation and potential vaginal delivery. We report the case of a 40-year-old gravida 3 para 0 woman diagnosed with type II vasa previa at 22 + 5 weeks. FLA was performed successfully at 31 + 5 weeks without complications. At 36 + 5 weeks, she experienced spontaneous rupture of membranes and delivered a healthy male neonate via cesarean section at maternal request. To contextualize this case, we conducted a systematic review of 54 cases from the literature. FLA was associated with a 98.1% technical success rate, 50% vaginal delivery rate, and 100% neonatal survival, with no major maternal complications reported. These findings suggest that FLA may offer a safe and effective alternative to preterm cesarean delivery in selected patients.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Ruano R, Mihulka O, Hombal A, et al. Fetoscopic Laser Ablation of Type II Vasa Previa-Case Report and Systematic Review. Prenat Diagn. 2025. PMID: 41024316. doi:10.1002/pd.6897

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。